Facilitating Optimal Outcomes for the Management of Retinal Diseases: Health Plan Best Practice Recommendations - Track 3: Spotlight on Retinal Vein Occlusion

By clicking the above I certify that I have reviewed the
CE information on this page.

Jointly Provided by
  

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

By clicking the above I certify that I have reviewed the CE information on this page.

Jointly provided by

  

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.